Structures by: Wan R.
Total: 67
As2O69W21,2(C12H18Cl3N18ORu3),5(O)
As2O69W21,2(C12H18Cl3N18ORu3),5(O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 9 2895-2904
a=18.3691(5)Å b=18.3890(6)Å c=22.2929(6)Å
α=90° β=108.3577(12)° γ=90°
As4KNaO144W42,2(C12H18Cl3N18ORu3),8(O)
As4KNaO144W42,2(C12H18Cl3N18ORu3),8(O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 9 2895-2904
a=20.0498(11)Å b=24.3323(11)Å c=25.4119(12)Å
α=89.231(2)° β=72.661(2)° γ=80.351(2)°
C12H4As6K16N4O238Pr4W58,13(O)
C12H4As6K16N4O238Pr4W58,13(O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 34 12956-12963
a=19.358(5)Å b=21.762(6)Å c=23.710(6)Å
α=101.789(5)° β=104.044(4)° γ=114.608(4)°
C8H4Dy2O90P2W22,6(C4H12N),10(O)
C8H4Dy2O90P2W22,6(C4H12N),10(O)
Journal of Materials Chemistry C (2016) 4, 5424-5433
a=22.277(5)Å b=13.120(3)Å c=52.440(12)Å
α=90° β=90° γ=90°
C8H4Er2O90P2W22,6(C4H12N),10(O)
C8H4Er2O90P2W22,6(C4H12N),10(O)
Journal of Materials Chemistry C (2016) 4, 5424-5433
a=22.1047(14)Å b=13.0665(9)Å c=52.158(4)Å
α=90° β=90° γ=90°
C8H4O90P2W22Yb2,6(C4H12N),10(O)
C8H4O90P2W22Yb2,6(C4H12N),10(O)
Journal of Materials Chemistry C (2016) 4, 5424-5433
a=22.1006(13)Å b=13.0302(7)Å c=51.964(3)Å
α=90° β=90° γ=90°
0.5(C12H24As4K8N4Ni4O230P12W56),19(O)
0.5(C12H24As4K8N4Ni4O230P12W56),19(O)
RSC Adv. (2015)
a=29.917(2)Å b=27.6712(18)Å c=20.6670(13)Å
α=90° β=122.3180(10)° γ=90°
0.5(C12H16As4K8Mn4N4O232P12W56),18(O)
0.5(C12H16As4K8Mn4N4O232P12W56),18(O)
RSC Adv. (2015)
a=29.848(4)Å b=27.794(4)Å c=20.700(3)Å
α=90° β=121.555(2)° γ=90°
0.5(C12H24As4Co4K8N4O230P12W56),19(O)
0.5(C12H24As4Co4K8N4O230P12W56),19(O)
RSC Adv. (2015)
a=29.8801(12)Å b=27.6391(11)Å c=20.6261(8)Å
α=90° β=122.1840(10)° γ=90°
0.25(C32H104As8Na16O368Pr8W84),6(H4O2)
0.25(C32H104As8Na16O368Pr8W84),6(H4O2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 6 1958-1965
a=19.802(5)Å b=28.389(8)Å c=21.365(9)Å
α=90° β=109.160(4)° γ=90°
C8H106As4K11O200Tb6W38
C8H106As4K11O200Tb6W38
Dalton transactions (Cambridge, England : 2003) (2019) 48, 8 2813-2821
a=15.320(2)Å b=18.945(3)Å c=19.928(3)Å
α=97.119(2)° β=99.267(2)° γ=102.633(3)°
C8H4As4Eu6K11O184W38,10(O)
C8H4As4Eu6K11O184W38,10(O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 8 2813-2821
a=12.627(2)Å b=18.389(3)Å c=23.142(4)Å
α=81.280(3)° β=80.406(3)° γ=80.720(3)°
C8H4As4Dy6K15O180.5W38,8.5(O)
C8H4As4Dy6K15O180.5W38,8.5(O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 8 2813-2821
a=19.5603(8)Å b=22.5308(9)Å c=26.0965(11)Å
α=91.6410(10)° β=100.0280(10)° γ=108.4640(10)°
LaO122P4W34,9(C4H12N),4(O)
LaO122P4W34,9(C4H12N),4(O)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 16 5398-5405
a=26.182(3)Å b=32.129(4)Å c=27.678(3)Å
α=90° β=93.992(2)° γ=90°
CeO122P4W34,9(C4H12N),4(O)
CeO122P4W34,9(C4H12N),4(O)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 16 5398-5405
a=26.1944(13)Å b=32.1245(15)Å c=27.6417(13)Å
α=90° β=94.0880(10)° γ=90°
0.5(C16H12As8Dy12K40Li4O360W76),O
0.5(C16H12As8Dy12K40Li4O360W76),O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 25 11514-11523
a=20.9096(13)Å b=25.3329(16)Å c=22.6800(15)Å
α=90.00° β=112.7400(10)° γ=90.00°
0.5(C16H12As8K40Li4O360Tb12W76),O
0.5(C16H12As8K40Li4O360Tb12W76),O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 25 11514-11523
a=20.924(3)Å b=25.288(4)Å c=22.707(4)Å
α=90.00° β=112.785(3)° γ=90.00°
0.5(C16H12As8Gd12K40Li4O360W76),O
0.5(C16H12As8Gd12K40Li4O360W76),O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 25 11514-11523
a=21.110(4)Å b=25.441(5)Å c=22.866(4)Å
α=90.00° β=112.883(4)° γ=90.00°
0.5(C16H12As8Eu12K40Li4O360W76),O
0.5(C16H12As8Eu12K40Li4O360W76),O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 25 11514-11523
a=21.063(11)Å b=25.446(14)Å c=22.740(12)Å
α=90.00° β=112.625(9)° γ=90.00°
0.5(C16H12As8K40Li4O360Sm12W76),O
0.5(C16H12As8K40Li4O360Sm12W76),O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 25 11514-11523
a=21.047(3)Å b=25.429(3)Å c=22.733(3)Å
α=90.00° β=112.774(2)° γ=90.00°
3-[5-(3,5-Dimethylphenyl)-1,3,4-thiadiazol-2-yl]-2-(4- methoxyphenyl)thiazolidin-4-one
C20H19N3O2S2
Acta Crystallographica Section E (2006) 62, 6 o2115-o2116
a=13.892(3)Å b=7.2560(15)Å c=18.912(4)Å
α=90.00° β=95.86(3)° γ=90.00°
3-[5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol-2-yl]-2-phenylthiazolidin-4-one
C17H11Cl2N3OS2
Acta Crystallographica Section E (2006) 62, 5 o1930-o1931
a=7.9700(16)Å b=6.1550(12)Å c=34.738(7)Å
α=90.00° β=90.20(3)° γ=90.00°
3-[5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-phenylthiazolidin-4-one
C17H12FN3OS2
Acta Crystallographica Section E (2006) 62, 2 o746-o747
a=6.4630(13)Å b=10.911(2)Å c=11.371(2)Å
α=97.91(3)° β=94.37(3)° γ=99.12(3)°
2-(4-Fluorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]thiazolidin- 4-one
C18H14FN3O2S2
Acta Crystallographica Section E (2006) 62, 9 o3984-o3985
a=17.750(4)Å b=6.3720(13)Å c=31.761(6)Å
α=90.00° β=101.55(3)° γ=90.00°
N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-3,5-dimethylbenzamide
C18H17N3O2S
Acta Crystallographica Section E (2006) 62, 10 o4412-o4413
a=7.7105(14)Å b=8.3328(18)Å c=14.454(2)Å
α=74.44(3)° β=83.07(3)° γ=69.18(3)°
(R)-Diethyl [(4-chlorophenyl)(5-m-tolyl-1,3,4-thiadiazol-2-ylamino)methyl]phosphonate
C20H23ClN3O3PS
Acta Crystallographica Section E (2007) 63, 2 o934-o935
a=9.772(2)Å b=11.104(2)Å c=12.588(3)Å
α=100.14(3)° β=109.80(3)° γ=111.17(3)°
(S)-Diethyl {(4-fluorophenyl)[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2- ylamino]methyl}phosphonate
C20H23FN3O4PS
Acta Crystallographica Section E (2007) 63, 10 o4158-o4158
a=9.4140(19)Å b=10.227(2)Å c=12.923(3)Å
α=110.44(3)° β=98.80(3)° γ=100.58(3)°
(R,S)-Diethyl {[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-ylamino](phenyl)methyl}phosphonate
C19H20Cl2N3O3PS
Acta Crystallographica Section E (2007) 63, 12 o4648-o4648
a=8.4870(17)Å b=16.530(3)Å c=15.703(3)Å
α=90.00° β=94.47(3)° γ=90.00°
2-(2,4-Dichlorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-1,3- thiazolidin-4-one
C18H13Cl2N3O2S2
Acta Crystallographica Section E (2008) 64, 5 o795
a=7.1310(14)Å b=8.1540(16)Å c=16.671(3)Å
α=93.19(3)° β=96.43(3)° γ=105.89(3)°
Dichloridobis(5-<i>m</i>-tolyl-1,3,4-thiadiazol-2-ylamine-κN^3^)zinc(II)
C18H18Cl2N6S2Zn
Acta Crystallographica Section E (2008) 64, 5 m692-m693
a=10.826(2)Å b=11.233(2)Å c=17.892(4)Å
α=90.00° β=90.10(3)° γ=90.00°
5-m-Tolyl-1,3,4-thiadiazol-2-ylamine
C9H9N3S
Acta Crystallographica Section E (2007) 63, 2 o717-o718
a=10.793(2)Å b=10.820(2)Å c=17.607(4)Å
α=73.85(3)° β=78.97(3)° γ=73.51(3)°
3-[5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-(4-methoxyphenyl)- 1,3-thiazolidin-4-one
C18H14FN3O2S2
Acta Crystallographica Section E (2008) 64, 7 o1359
a=6.4550(13)Å b=8.9200(18)Å c=16.483(3)Å
α=75.78(3)° β=82.44(3)° γ=71.11(3)°
2-Methoxy-<i>N</i>-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]benzamide hemihydrate
C17H15N3O3S,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 8 o1637
a=29.950(6)Å b=14.561(3)Å c=7.6520(15)Å
α=90.00° β=94.78(3)° γ=90.00°
3-{5-[3-(Trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}- 2-phenylthiazolidin-4-one
C18H12F3N3OS2
Acta Crystallographica Section E (2006) 62, 9 o4072-o4074
a=7.5370(15)Å b=10.538(2)Å c=11.380(2)Å
α=79.86(3)° β=78.03(3)° γ=84.70(3)°
Rac-Diethyl {[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-ylamino](phenyl)methyl}phosphonate
C19H21FN3O3PS
Acta Crystallographica Section E (2007) 63, 3 o1304-o1305
a=9.874(2)Å b=15.415(3)Å c=14.412(3)Å
α=90.00° β=104.17(3)° γ=90.00°
N-benzylidene-5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-amine
C16H13N3OS
Acta Crystallographica Section E (2007) 63, 5 o2363-o2364
a=7.4253(7)Å b=11.5124(11)Å c=33.0405(19)Å
α=90.00° β=93.10(3)° γ=90.00°
2-(2,4-Dichlorophenyl)-3-[5-(3,5-dimethylphenyl)-1,3,4-thiadiazol-2- yl]thiazolidin-4-one
C19H15Cl2N3OS2
Acta Crystallographica Section E (2008) 64, 1 o260-o260
a=8.1760(16)Å b=9.1650(18)Å c=14.483(3)Å
α=80.60(3)° β=80.82(3)° γ=63.92(3)°
5-(2-Bromophenyl)-1,3,4-thiadiazol-2-amine
C8H6BrN3S
Acta Crystallographica Section E (2008) 64, 10 o1884
a=14.869(3)Å b=8.0250(16)Å c=7.9480(16)Å
α=90.00° β=97.43(3)° γ=90.00°
2-(4-Chlorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]thiazolidin- 4-one
C18H14ClN3O2S2
Acta Crystallographica Section E (2006) 62, 11 o5274-o5275
a=6.4380(13)Å b=31.803(6)Å c=9.2650(19)Å
α=90.00° β=109.08(3)° γ=90.00°
5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-ylamine
C8H6FN3S
Acta Crystallographica Section E (2006) 62, 12 o5547-o5548
a=8.8020(18)Å b=8.9610(18)Å c=11.035(2)Å
α=90.00° β=97.19(3)° γ=90.00°
3,5-Dimethyl-N-[5-(3-tolyl)-1,3,4-thiadiazol-2-yl]benzamide
C18H17N3OS
Acta Crystallographica Section E (2007) 63, 2 o885-o886
a=8.6420(17)Å b=9.0980(18)Å c=10.924(2)Å
α=84.08(3)° β=72.59(3)° γ=79.42(3)°
<i>N</i>-{(<i>E</i>)-4-[(<i>E</i>)-(Dodecylimino)methyl]benzylidene}dodecan-\ 1-imine ?
C32H56N2
Acta Crystallographica Section E (2008) 64, 3 o565
a=4.7370(9)Å b=5.5190(11)Å c=30.315(6)Å
α=91.18(3)° β=93.44(3)° γ=101.75(3)°
Diethyl {(4-methoxyphenyl)[5-(4-nitrophenyl)-1,3,4-thiadiazol-2- ylamino]methyl}phosphonate
C20H23N4O6PS
Acta Crystallographica Section E (2008) 64, 8 o1376
a=11.481(2)Å b=19.426(4)Å c=11.960(2)Å
α=90.00° β=117.08(3)° γ=90.00°
5-(2,6-Difluorophenyl)-1,3,4-thiadiazol-2-amine
C8H5F2N3S
Acta Crystallographica Section E (2009) 65, 12 o3108
a=9.0920(18)Å b=8.7400(17)Å c=10.936(2)Å
α=90.00° β=95.85(3)° γ=90.00°
5-(4-methylphenyl)-1,3,4-thiadiazol-2-amine
C9H9N3S
Acta Crystallographica Section E (2009) 65, 5 o976
a=12.284(3)Å b=7.3730(15)Å c=11.263(2)Å
α=90.00° β=109.09(3)° γ=90.00°
5-(4-Phenoxyphenyl)-1,3,4-thiadiazol-2-amine
C14H11N3OS
Acta Crystallographica Section E (2009) 65, 5 o1044
a=13.409(3)Å b=10.582(2)Å c=9.5710(19)Å
α=90.00° β=108.58(3)° γ=90.00°
5-(4-Pyridyl)-1,3,4-thiadiazol-2-amine
C7H6N4S
Acta Crystallographica Section E (2009) 65, 5 o1099
a=14.794(3)Å b=10.686(2)Å c=10.477(2)Å
α=90.00° β=106.52(3)° γ=90.00°
5-(4-Pentylphenyl)-1,3,4-thiadiazol-2-amine
C13H17N3S
Acta Crystallographica Section E (2009) 65, 7 o1608
a=14.012(3)Å b=9.1300(18)Å c=10.938(2)Å
α=90.00° β=100.64(3)° γ=90.00°
2-(4-Fluorobenzylidene)-<i>N</i>-(4-methoxybenzylidene)-1,3,4-thiadiazol-2-amine
C16H12FN3OS
Acta Crystallographica Section E (2010) 66, 7 o1716
a=7.4580(15)Å b=17.821(4)Å c=10.891(2)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-<i>N</i>-(4-Chlorobenzylidene)-5-(4-methylphenyl)-1,3,4- thiadiazol-2-amine
C16H12ClN3S
Acta Crystallographica Section E (2011) 67, 4 o861
a=5.7940(12)Å b=8.7510(18)Å c=14.965(3)Å
α=98.64(3)° β=90.66(3)° γ=99.45(3)°
5-(2,3,4,5,6-Pentafluorophenyl)-1,3,4-thiadiazol-2-amine
C8H2F5N3S
Acta Crystallographica Section E (2010) 66, 11 o2765
a=11.897(2)Å b=7.0680(14)Å c=11.553(2)Å
α=90.00° β=104.66(3)° γ=90.00°
Diethyl {[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-ylamino](4- methoxyphenyl)methyl}phosphonate
C20H22Cl2N3O4PS
Acta Crystallographica Section E (2009) 65, 5 o983
a=9.7100(19)Å b=11.825(2)Å c=11.845(2)Å
α=98.74(3)° β=112.16(3)° γ=103.05(3)°
5-(2-Methylphenyl)-1,3,4-thiadiazol-2-amine
C9H9N3S
Acta Crystallographica Section E (2009) 65, 5 o961
a=10.792(2)Å b=7.3400(15)Å c=11.831(2)Å
α=90.00° β=96.15(3)° γ=90.00°
5-(2-Fluoro-4-nitrophenyl)-1,3,4-thiadiazol-2-amine
C8H5FN4O2S
Acta Crystallographica Section E (2009) 65, 6 o1250
a=9.1780(18)Å b=9.3720(19)Å c=11.413(2)Å
α=90.00° β=102.55(3)° γ=90.00°
5-(3-Fluorophenyl)-1,3,4-thiadiazol-2-amine
C8H6FN3S
Acta Crystallographica Section E (2009) 65, 6 o1425
a=11.345(2)Å b=7.3130(15)Å c=11.269(2)Å
α=90.00° β=111.64(3)° γ=90.00°
5-(3-Pyridyl)-1,3,4-thiadiazol-2-amine
C7H6N4S
Acta Crystallographica Section E (2009) 65, 6 o1447
a=11.066(2)Å b=7.2380(14)Å c=11.271(2)Å
α=90.00° β=116.79(3)° γ=90.00°
5-(2,4-Dichlorophenoxymethyl)-1,3,4-thiadiazol-2-amine
C9H7Cl2N3OS
Acta Crystallographica Section E (2009) 65, 8 o1761
a=16.012(3)Å b=6.5840(13)Å c=11.225(2)Å
α=90.00° β=105.65(3)° γ=90.00°
Dichloridobis(5-heptyl-1,3,4-thiadiazol-2-amine-κ<i>N</i>^3^)zinc(II)
C18H34Cl2N6S2Zn
Acta Crystallographica Section E (2009) 65, 9 m1086
a=8.1750(16)Å b=11.663(2)Å c=14.666(3)Å
α=73.150(17)° β=77.83(2)° γ=88.81(3)°
<i>N</i>-{<i>N</i>-[5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol- 2-yl]carbamoyl}-2,6-difluorobenzamide
C16H8Cl2F2N4O2S
Acta Crystallographica Section E (2009) 65, 11 o2946
a=8.1600(16)Å b=7.6100(15)Å c=27.102(5)Å
α=90.00° β=92.42(3)° γ=90.00°
2-(4-Fluorophenyl)-3-[5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl]- 1,3-thiazolidin-4-one
C17H11FN4O3S2
Acta Crystallographica Section E (2010) 66, 7 o1737
a=7.2360(14)Å b=9.1340(18)Å c=14.464(3)Å
α=71.67(2)° β=87.16(3)° γ=75.69(2)°
Methyl 2-(<i>tert</i>-butoxycarbonylamino)-1,3-thiazole-5-carboxylate
C10H14N2O4S
Acta Crystallographica Section E (2010) 66, 9 o2343
a=7.0700(14)Å b=9.2580(19)Å c=10.708(2)Å
α=70.10(3)° β=79.67(3)° γ=79.08(3)°
1-(3-Chloropyridin-2-yl)hydrazine
C5H6ClN3
Acta Crystallographica Section E (2010) 66, 10 o2599
a=11.637(2)Å b=3.9060(8)Å c=13.946(3)Å
α=90.00° β=103.46(3)° γ=90.00°
5-(4-Bromo-2-nitrophenyl)-1,3,4-thiadiazol-2-amine
C8H5BrN4O2S
Acta Crystallographica Section E (2011) 67, 9 o2255
a=11.231(2)Å b=9.2580(19)Å c=10.868(2)Å
α=90.00° β=113.08(3)° γ=90.00°
2-Chloro-<i>N</i>-[1-(4-chlorophenyl)-3-cyano-1<i>H</i>-pyrazol-5-yl]acetamide
C12H8Cl2N4O
Acta Crystallographica Section E (2012) 68, 11 o3249
a=18.493(4)Å b=13.815(3)Å c=5.0600(10)Å
α=90.00° β=90.00° γ=90.00°
2-Chloro-<i>N</i>-{3-cyano-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]- 1<i>H</i>-pyrazol-5-yl}acetamide
C13H6Cl3F3N4O
Acta Crystallographica Section E (2012) 68, 1 o104
a=8.4190(17)Å b=9.2650(19)Å c=11.944(2)Å
α=69.77(3)° β=76.74(3)° γ=66.10(3)°
5-Amino-1-(4-nitrophenyl)-1<i>H</i>-pyrazole-3-carbonitrile
C10H7N5O2
Acta Crystallographica Section E (2012) 68, 1 o65
a=3.7685(2)Å b=27.3441(17)Å c=10.1294(8)Å
α=90.00° β=96.20(3)° γ=90.00°
0.5(C2Ce22O418P12W96),13(O),6(C4H12N),C4H10N
0.5(C2Ce22O418P12W96),13(O),6(C4H12N),C4H10N
Inorganic chemistry (2016) 55, 2 918-924
a=28.2062(10)Å b=31.0697(11)Å c=40.1622(14)Å
α=90° β=90° γ=90°